These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2431666)
1. Occurrence of ABO group antigens in bladder carcinoma. Schlesinger D; Stolarczyk J; Błaszczuk J Arch Immunol Ther Exp (Warsz); 1986; 34(2):171-4. PubMed ID: 2431666 [TBL] [Abstract][Full Text] [Related]
2. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium]. Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774 [TBL] [Abstract][Full Text] [Related]
3. [ABO(H) cell surface antigens in carcinoma of urinary bladder: its correlation with grade, stage and clinical course]. Dong SG Zhonghua Wai Ke Za Zhi; 1983 Sep; 21(9):513-6. PubMed ID: 6676042 [No Abstract] [Full Text] [Related]
4. [Blood group ABO (H) cell surface antigens in bladder tumours invading the chorion. Prognostic value of their determination by immunofluorescence. Retrospective study of one hundred and twenty-five cases]. Vacant J; Le Portz B; Augustin I; Hammou JC; Fella C; Délignières S; Maïolini R; Masseyeff R; Abelanet R; Steg A Sem Hop; 1982 May; 58(21):1295-300. PubMed ID: 6287585 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder]. Borella T; Loro M; Dato I; Merlo F; Giudici M Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921 [TBL] [Abstract][Full Text] [Related]
6. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)]. Vallancien G; Rouger P; Leclerc JP; Kuss R Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497 [TBL] [Abstract][Full Text] [Related]
7. Random biopsies in bladder tumors: in most cases, you shall not! Zlotta AR Eur Urol; 2006 Aug; 50(2):186-93. PubMed ID: 16814925 [No Abstract] [Full Text] [Related]
8. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder]. Hammou JC; Fella C; Vacant J Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793 [No Abstract] [Full Text] [Related]
9. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)]. Gelabert Mas A; Corominas J; Arango O Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059 [No Abstract] [Full Text] [Related]
10. [Erythrocyte adherence test for identifying A, B and O(H) antigens in preneoplastic and neoplastic lesions of the bladder urothelium]. Bertoni F; Mattarozzi A; Bacchini P Pathologica; 1982; 74(1032):449-61. PubMed ID: 7162862 [No Abstract] [Full Text] [Related]
11. [Specific erythrocyte adherence reaction: an index of the malignant potentials of noninvasive tumors of the human urothelium]. Anichkov NM; Anichkova SI Vopr Onkol; 1980; 26(8):9-13. PubMed ID: 7415061 [TBL] [Abstract][Full Text] [Related]
12. Blood group antigens in epithelial tumours of the urinary bladder. Marek J; Hradec E; Hanus M; Smolová H Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171 [TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors]. Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765 [TBL] [Abstract][Full Text] [Related]
14. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection]. Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638 [No Abstract] [Full Text] [Related]
15. [Modification of the expressivity of blood group antigens in urothelial bladder tumors. Prognostic value]. Roth A; Le Cuziat N; Cukier J J Urol (Paris); 1983; 89(4):225-31. PubMed ID: 6350478 [TBL] [Abstract][Full Text] [Related]
16. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder]. Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025 [TBL] [Abstract][Full Text] [Related]
17. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression]. Srougi M; Alves VA; Gayotto LC; Arap S Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591 [No Abstract] [Full Text] [Related]
18. Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma. Cordon-Cardo C; Reuter VE; Lloyd KO; Sheinfeld J; Fair WR; Old LJ; Melamed MR Cancer Res; 1988 Jul; 48(14):4113-20. PubMed ID: 2454735 [TBL] [Abstract][Full Text] [Related]
19. [Distribution of ABH antigens in tumours of the bladder. A retrospective immunofluorescence study (author's transl)]. Rouger P; Vallancien G; Leclerc JP; Gane P; Salmon C Nouv Presse Med; 1982 Feb; 11(6):419-21. PubMed ID: 7038622 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]